Polyrizon

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Polyrizon and other ETFs, options, and stocks.

About PLRZ

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. 

CEO
Tomer Izraeli
CEOTomer Izraeli
Employees
6
Employees6
Headquarters
Raanana, Tel Aviv
HeadquartersRaanana, Tel Aviv
Founded
2005
Founded2005
Employees
6
Employees6

PLRZ Key Statistics

Market cap
28.76M
Market cap28.76M
Price-Earnings ratio
-5.11
Price-Earnings ratio-5.11
Dividend yield
Dividend yield
Average volume
38.50K
Average volume38.50K
High today
$15.50
High today$15.50
Low today
$12.28
Low today$12.28
Open price
$12.60
Open price$12.60
Volume
116.86K
Volume116.86K
52 Week high
$18.20
52 Week high$18.20
52 Week low
$2.88
52 Week low$2.88

Stock Snapshot

With a market cap of 28.76M, Polyrizon(PLRZ) trades at $13.80. The stock has a price-to-earnings ratio of -5.11.

As of 2026-07-05, Polyrizon(PLRZ) stock has fluctuated between $12.28 and $15.50. The current price stands at $13.80, placing the stock +12.4% above today's low and -11.0% off the high.

The Polyrizon(PLRZ)'s current trading volume is 116.86K, compared to an average daily volume of 38.5K.

During the past year, Polyrizon(PLRZ) stock moved between $2.88 at its lowest and $18.20 at its peak.

During the past year, Polyrizon(PLRZ) stock moved between $2.88 at its lowest and $18.20 at its peak.

PLRZ News

TipRanks 2d
Polyrizon Clears Key Safety Milestone for NASARIX Allergy Nasal Spray

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

TipRanks 6d
Polyrizon receives central IRB approval for Nasarix

Polyrizon (PLRZ) announced it has received central IRB approval to begin its first human clinical trial for Nasarix, the company’s nasal spray designed to block...

People also own

Based on the portfolios of people who own PLRZ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.